Atrial Fibrillation (AF) has become the most common arrhythmia in the world. In developed nations worldwide, 6.0% of men and 5.1% of women can expect to develop AF during the course of their lives. (The Rotterdam Study 1990-93, n=6,808, Copyright 2012 European Society of Cardiology). It’s especially likely to alter a patient’s course of recovery when it happens in the 5-hour window following heart surgery. Some clinicians call this the “AF Danger Window.”
The Rindex Medical A-50 AF Prediction System is an investigational device only. Not available for sale in the U.S.A. U.S. clinicians interested in participating in research involving predicting the onset of atrial fibrillation in cardiac surgery post-operative patients should contact us at firstname.lastname@example.org.
AF has become the most prevalent cardiac arrhythmia in the world. Most clinical statisticians believe that over 2 million people in the United states and over 4 million people in Europe have AF, many of whom have not yet been diagnosed. Patients are particularly vulnerable to the condition in the five days following cardiac surgery. It is during this time period, where AF could be treated prophylactically but typically isn’t because clinicians lack a tool for predicting it, when intervention could make a difference to clinical outcome.
Research performed at the Cleveland Clinic now indicates that most cardiac surgery patients who develop AF actually give off clues beforehand – subtle combinations of changes in their ECG readings that are not currently perceptible, even under CVICU best practices today. Rindex Medical is dedicated to developing technology to detect ECG changes that today go unnoticed and provide CVICU clinicians with a tool to predict the onset of AF in the hours before it happens.
Cardiovascular Intensive Care Units (CVICUs) must remain vigilant to notice and treat AF when it occurs. But today, no tool exists to help predict the onset of AF before it occurs.